Fiona Sarazin

Feb 13, 2024 | lexblog.com | Fiona Sarazin |Christopher A. Guerreiro |Kristin Wall

The Federal Court (FC) has found the brand name of a biologic drug to be confusingly similar to the brand name of a drug used to treat the same disorder, but with a different active ingredient. The application of the ordinary test for trademark confusion was not affected by the fact that the names of both products had been approved by Health Canada. Novartis AG and Novartis Pharmaceuticals Canada Inc.

Mar 15, 2023 | digitalcommons.osgoode.yorku.ca | Fiona Sarazin

Document TypeBook ReviewCitation InformationSarazin, Fiona. "Neurointerventions, Crime, and Punishment: Ethical Considerations, by Jesper Ryberg."Osgoode Hall Law Journal 58.2 (2021): https://digitalcommons.osgoode.yorku.ca/ohlj/vol58/iss2/20